OMN 7
Alternative Names: OMN-7Latest Information Update: 07 Nov 2022
At a glance
- Originator Omnix Medical
- Class Antibacterials; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acinetobacter infections
Most Recent Events
- 03 Nov 2022 Discontinued for Acinetobacter infections in Israel (Inhalation) before November 2022 (Omnix Medical pipeline, November 2022)
- 18 Jan 2019 Early research in Acinetobacter infections in Israel (Inhalation) before January 2019 (Omnix Medical pipeline, January 2019)